Relenza antiviral drug

Relenza antiviral drug

C001/9404 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 51.1MB

Downloadable file size: 1.2MB

Price image Pricing

Please login to use the price calculator


Credit: MARK THOMAS/SCIENCE PHOTO LIBRARY

Caption: Relenza antiviral drug being held in a pharmacist's hand. Relenza is the trade name for the antiviral drug zanamivir. It is administered in spray form for inhalation, and reduces the length of an attack of influenza (flu) if taken early in the course of the disease. It works by blocking the enzyme neuraminidase, which is found on the surface of the influenza virus. Relenza was the first such drug on the market.

Release details: Model release not required. Property release not required.

Keywords: adult, anti-viral viral, antiviral, box, caucasian, chemist, clinic, close-up, detail, dispensing, dispensory, drug, epidemic, flu, glaxosmithkline, gsk, holding, human, influenza, inhalation, medical, medicine, neuraminidase inhibitor, packaged, packaging, packet, pandemic, people, person, pharmaceutic, pharmaceutical, pharmaceutics, pharmacist, pharmacological, pharmacology, pharmacy, prescribed, prescription drug, relenza, swine flu, treatment, white, zanamivir

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.